Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G3EU
|
||||
| Former ID |
DIB010550
|
||||
| Drug Name |
AMG-139
|
||||
| Synonyms |
Anti-inflammatory agent (psoriasis, IBD), Amgen
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Crohn's disease [ICD9: 555; ICD10:K50] | Phase 1 | [523286] | ||
| Company |
Amgen; astrazeneca
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-23 ligand | Target Info | [532948] | ||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Toll-like receptor signaling pathway | |||||
| RIG-I-like receptor signaling pathway | |||||
| Jak-STAT signaling pathway | |||||
| Type I diabetes mellitus | |||||
| Pertussis | |||||
| Legionellosis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| African trypanosomiasis | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Tuberculosis | |||||
| Measles | |||||
| Influenza A | |||||
| Herpes simplex infection | |||||
| Inflammatory bowel disease (IBD) | |||||
| Allograft rejection | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.